L
Ludhmila Abrahão Hajjar
Researcher at University of São Paulo
Publications - 242
Citations - 8857
Ludhmila Abrahão Hajjar is an academic researcher from University of São Paulo. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 39, co-authored 214 publications receiving 6499 citations. Previous affiliations of Ludhmila Abrahão Hajjar include Sapienza University of Rome & Università Campus Bio-Medico.
Papers
More filters
Journal ArticleDOI
Prognostic value of coronary and microvascular flow reserve in patients with nonischemic dilated cardiomyopathy.
Marta F. Lima,Wilson Mathias,João C.N. Sbano,Victoria Cruz,Maria Cristina Donadio Abduch,Márcio Silva Miguel Lima,E A Bocchi,Ludhmila Abrahão Hajjar,José Antonio Franchini Ramires,Roberto Kalil Filho,Jeane M. Tsutsui +10 more
TL;DR: Increased left atrial diameter and depressed β reserve were independent predictors of cardiac death and transplantation in patients with nonischemic dilated cardiomyopathy and Beta reserve by RTMPE provided incremental predictive value beyond that provided by current known prognostic clinical and echocardiographic factors.
Journal ArticleDOI
Cardiovascular Imaging and Interventional Procedures in Patients with Novel Coronavirus Infection
Isabela Bispo Santos da Silva Costa,Carlos E. Rochitte,Carlos M. Campos,Silvio Henrique Barberato,Gláucia Maria Moraes de Oliveira,Marcelo Antônio Cartaxo Queiroga Lopes,Cesar Higa Nomura,Alexandre Abizaid,Giovanni Guido Cerri,Roberto Kalil Filho,Ludhmila Abrahão Hajjar +10 more
TL;DR: This review was aimed at guiding health professionals in safely and effectively performing imaging exams and interventional procedures in the coronavirus disease 2019 pandemic.
Journal ArticleDOI
Strategies to reduce blood transfusion: a Latin-American perspective.
Ludhmila Abrahão Hajjar,Julia Tizue Fukushima,Juliano Pinheiro de Almeida,Eduardo A Osawa,Filomena Regina Barbosa Gomes Galas +4 more
TL;DR: The aim of this review is to discuss the risks of anemia and blood transfusion, and to describe recent developments in the strategies to reduce allogeneic blood transfusions.
Journal ArticleDOI
A plea for personalization of the hemodynamic management of septic shock
Daniel De Backer,Maurizio Cecconi,Michelle S Chew,Ludhmila Abrahão Hajjar,Xavier Monnet,Gustavo A. Ospina-Tascón,Marlies Ostermann,Michael R. Pinsky,Jean Louis Vincent +8 more
TL;DR: In this paper , a personalized approach for septic shock management is proposed, based on clinical evaluation and blood flow measurements to avoid excessive vasoconstriction, and the authors suggest as the first test a limited dose of dobutamine, to add enoximone or milrinone in the second line and substitute or add levosimendan if inefficient.
Journal ArticleDOI
Efficacy and safety of IL-6 inhibitors in patients with COVID-19 pneumonia: a systematic review and meta-analysis of multicentre, randomized trials.
Alessandro Belletti,Corrado Campochiaro,Marilena Marmiere,Valery Likhvantsev,Andrey Yavorovskiy,Lorenzo Dagna,Giovanni Landoni,Alberto Zangrillo,Ludhmila Abrahão Hajjar +8 more
TL;DR: Administration of IL-6 inhibitors may reduce all-cause longest follow-up mortality and need for intubation in COVID-19 patients, without increasing risk of adverse events, however, these findings need to be confirmed in high-quality randomized controlled trials.